Merck Canada Inc.

Canada


 
Quantité totale PI 89
Rang # Quantité totale PI 14 803
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 661 095
Parent Merck & Co., Inc.
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

27 0
4 20
38 0
0
 
Dernier brevet 2016 - Tetrahydronaphthyridine derivati...
Premier brevet 1994 - Dna encoding prostaglandin recep...
Dernière marque 1998 - CIRCLE DESIGN
Première marque 1936 - SCHERING TRADE MARK SCHERING COR...

Industrie (Classification de Nice)

Derniers inventions, produits et services

2015 Invention Tetrahydronaphthyridine derivatives as mglur2-negative allosteric modulators, compositions, and t...
Invention Hiv protease inhibitors. The present invention is directed to 2,6-morpholine derivatives of Formu...
2014 Invention Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors. The invention provide...
Invention Hiv protease inhibitors. The present invention is directed to 5-heteroarylmorpholine derivatives ...
Invention Hiv protease inhibitors. The present invention is directed to 2,5,6-substituted morpholine deriva...
2013 Invention Triazolyl derivatives as syk inhibitors. Provided are triazole derivatives of Formula I which are...
Invention Hiv protease inhibitors. The compounds encompassed by Formula I include compounds which are HIV p...
Invention Substituted phenyl spleen tyrosine kinase (syk) inhibitors. The invention provides certain substi...
Invention Hcv ns3 protease inhibitors. The present invention relates to hepatitis C virus (HCV) NS3 proteas...
Invention Non-nucleoside reverse transcriptase inhibitors. Heteroaromatic compounds of Formula I: Hetero...
Invention Pyrazolyl derivatives as syk inhibitors. The present invention provides novel pyrazole derivative...
Invention Imidazolyl analogs as syk inhibitors. The present invention provides novel imidazole analogs of F...
Invention Substituted pyridine spleen tyrosine kinase (syk) inhibitors. The invention provides certain subs...
Invention Cysteine protease inhibitors for the treatment of parasitic diseases. ascariasis, trichuriasis, s...
2012 Invention Hcv ns3 protease inhibitors. The present invention relates to macrocyclic compounds of formula (I...
Invention Hiv protease inhibitors. 7 are defined herein. The compounds encompassed by Formula I include com...
Invention Hiv protease inhibitors. Compounds of Formula I are disclosed: wherein A, R1, R2, R3, R4A, R4B, R...
Invention Scd inhibitors for the treatment of hcv. The present invention relates to methods of treating, pr...
Invention Bipyridylaminopyridines as syk inhibitors. The present invention provides novel pyrimidine amines...
2011 Invention Hiv protease inhibitors. 9 are defined herein. The compounds encompassed by Formula I include com...
Invention Sulfonamides as hiv protease inhibitors. 7 are defined herein. The compounds encompassed by Formu...
Invention Sulfonamides as hiv protease inhibitors. Compounds of Formula I are disclosed: wherein L, A, R1, ...
Invention Hiv protease inhibitors. Compounds of Formula I are disclosed wherein R1, R2, R3A, R3B, R4A, R4B,...
Invention Hiv integrase inhibitors. Tricyclic compounds of Formula I are inhibitors of HIV integrase and in...
Invention 2-oxo-dihydropyridine non-nucleoside reverse transcriptase inhibitors. Heteroaromatic compounds o...
Invention Non-nucleoside reverse transcriptase inhibitors. Heteroaromatic compounds of Formula I: (I) are H...
Invention Non-nucleoside reverse transcriptase inhibitors. Heteroaromatic compounds of Formula I: 5 are de...
Invention Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials. The present...
2010 Invention Aminopyrimidines as syk inhibitors. The present invention provides novel pyrimidine amines of for...
Invention Spirocyclic piperidine derivatives useful as renin inhibitors. Renin inhibitors which are spiroc...
Invention Spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase. Heteroaromatic co...
Invention Cathepsin cysteine protease inhibitors for the treatment of various diseases. The present invent...
Invention Renin inhibitors. The present invention relates to biaryl piperidine-based renin inhibitor compo...
Invention Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase. Heterocyclic com...
Invention Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase. Heterocyclic c...
2009 Invention Renin inhibitors. The present invention relates to 3,4-substituted piperidinyl—based renin inhib...
Invention Transdermally administered aliskiren. Dosage form of aliskiren, comprising a device for transder...
Invention Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase. Azetidine derivat...
Invention Indole derivatives as crth2 receptor antagonists. The compound (+) {7R-[[(4-fluorophenyl)sulfonyl...
Invention Azaindole derivatives as crth2 receptor antagonists. Compounds of formula I are antagonists of th...
Invention Indole derivatives as crth2 receptor antagonists. Compound of formula I are antagonists of the PG...
Invention 3,4-substituted piperidine derivatives as renin inhibitors. The present invention relates to 3,4...
2008 Invention Renin inhibitors. The present invention relates to acyclic amino amide renin inhibitor compounds...
1998 P/S Pharmaceutical preparation to treat cancer.
P/S Allergy products namely, antihistamines, decongestants and steroid preparations to treat allergie...
1995 P/S Publications, namely newsletters, brochures, handouts, magazines, advertising materials, audio an...
1994 P/S Alkylating cytotoxic agent for the treatment of various types of cancer.
1993 P/S Foot care preparations, namely corn removal preparations, foot bath preparations, foot powders, f...
1989 P/S Pharmaceutical preparations namely, dermatological preparations, topical dermatologies, psychopha...
1984 P/S Pharmaceutical preparation, namely a non-steroidal, orally-active antiandrogen preparation.
1983 P/S Nonradioactive precursors for the production of radiopharmaceuticals; radiological contrast media...
1978 P/S Pharmaceutical preparations, namely a heparin solution.
1969 P/S Pharmaceutical preparations.
1955 P/S Pharmaceuticals.
1953 P/S Drugs, including pharmaceuticals and medicaments of animal, vegetable and mineral origin, toothpa...
1950 P/S A chemical compound to be used in the treatment or prevention of streptococcal, gonococcal, pneum...
P/S Medicinal estrogenic hormone preparation.
1938 P/S Pharmaceutical tablets for medicinal use.
1936 P/S Medicinal preparations recommended for the treatment of disordersof the stomach and digestive org...